PCI — Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System Class II

FDA Device Classification

Classification Details

Product Code
PCI
Device Class
Class II
Regulation Number
866.3990
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A gastrointestinal bacterial panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal bacterial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal bacterial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K250358becton, dickinson andBD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus foOctober 31, 2025
K214122becton, dickinson andBD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial PanelJuly 28, 2022
K173330micronicsPanNAT STEC TestJune 1, 2018
K163571great basin scientificGreat Basin Stool Bacterial Pathogens PanelJuly 12, 2017
K140111becton, dickinson andBD MAX(TM) ENTERIC BACTERIAL PANEL;BD MAX(TM) INSTRUMENTMay 6, 2014